Tradestie Institutional Equity Comparison Engine

VRTX vs MAIA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VRTX Overall Edge

VRTX Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vertex Pharmaceuticals Inc (VRTX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while MAIA counters with relative strength in Valuation. Fundamentally, VRTX trades at 25.9x Forward P/E with 37.8% operating margin (+11.8% YoY revenue) versus MAIA at 1.2x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, VRTX sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro) against MAIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MAIA
VRTX 25.9x vs MAIA 1.2x Fwd P/E
Growth & Margin Winner VRTX
Op Margin 37.8% vs 0.0% ยท YoY +11.8% vs +0.0%
Momentum & Technical Winner VRTX
1Y +22.3% vs +20.6% ยท 52W Pos 66% vs 10%
Options & Structure Winner VRTX
CONSOLIDATION (33rd %ile IV) vs UNCLASSIFIED (N/A IV)
VRTX NASDAQ
Vertex Pharmaceuticals Inc
Pharmaceutical Preparations
$515.02
-1.08% 1D
Market Cap $132.0B
1M Return -3.77%
1Y Return +22.32%
Forward P/E 25.9x
Unified AI Score
40.9 / 100 SELL
Tech 25.0 Fund 47.0 Flow 69.0 Mom 46.0
MAIA NYSE American
MAIA Biotechnology, Inc.
Pharmaceutical Preparations
$1.11
-2.63% 1D
Market Cap $68.5M
1M Return -1.77%
1Y Return +20.65%
Forward P/E 1.2x
Unified AI Score
37.6 / 100 SELL
Tech 40.0 Fund 38.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VRTX +22.32% MAIA +20.65% Spread: +1.67 pp (VRTX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VRTX TTM Op. Margin: 37.8% MAIA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VRTX vs MAIA. Trailing 12-month operating profitability (VRTX 37.8% vs MAIA 0.0%) and valuation multiples (VRTX 25.9x vs MAIA 1.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VRTX (8) vs MAIA (2)
Institutional Metric VRTX MAIA Criterion Row Winner
Market Capitalization Scale $132.0B $68.5M Larger Scale VRTX
Trailing P/E Ratio Valuation 33.5x 1.2x Lower Multiple MAIA
Forward P/E Ratio Valuation 25.9x 1.2x Lower Multiple MAIA
Revenue Growth (YoY) Growth +11.8% +0.0% Higher Growth VRTX
Operating Margin (TTM) Profitability 37.8% 0.0% Higher Margin VRTX
Net Profit Margin Profitability 30.7% 0.0% Higher Margin VRTX
Return on Equity (ROE) Capital Efficiency 20.8% -341.5% Higher ROE VRTX
52-Week Range Position Momentum 66% ($412โ€“$569) 10% ($1โ€“$3) Stronger Trend VRTX
Beta / 30D Volatility Risk Regime 0.35ฮฒ ยท 28% Vol 1.65ฮฒ ยท 108% Vol Lower Realized Risk VRTX
Unified Institutional Score Composite Signal 40.9 / 100 (SELL) 37.6 / 100 (SELL) Higher Composite VRTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VRTX vs MAIA Buy Guide
VRTX CONSOLIDATION
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 33rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VRTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MAIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MAIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VRTX nor MAIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.